In vitro activities of linezolid and telithromycin against beta lactam, macrolide, and fluoroquinolone-resistant Streptococcus pneumoniae.

被引：0
|
作者：
Fu, K [1 ]
Johnson, C [1 ]
Herring, S [1 ]
Waites, K [1 ]
机构：
[1] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2001年 / 116卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
11
引用
收藏
页码：281 / 282
页数：2
相关论文
共 50 条
  • [31] Determination of the costs associated with the inpatient treatment of infections caused by macrolide-resistant Streptococcus pneumoniae.
    Klepser, DG
    Klepser, ME
    PHARMACOTHERAPY, 2003, 23 (10): : 1354 - 1354
  • [32] Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae
    Brenwald, NP
    Gill, MJ
    Wise, R
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) : 2032 - 2035
  • [33] The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro susceptibilities of fluoroquinolone-resistant strains of Streptococcus pneumoniae to norfloxacin
    Brenwald, NP
    Gill, MJ
    Wise, R
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (03) : 458 - 460
  • [34] Antibacterial and anti-PmrA activity of plant essential oils against fluoroquinolone-resistant Streptococcus pneumoniae clinical isolates
    Ghafari, O.
    Sharifi, A.
    Ahmadi, A.
    Fasaei, B. Nayeri
    LETTERS IN APPLIED MICROBIOLOGY, 2018, 67 (06) : 564 - 569
  • [35] Comparative activity of telithromycin against macrolide-resistant isolates of Streptococcus pneumoniae:: Results of two years of the PROTEKT surveillance study
    Schito, GC
    Marchese, A
    Elkharrat, D
    Farrell, DJ
    JOURNAL OF CHEMOTHERAPY, 2004, 16 (01) : 13 - 22
  • [36] In vitro activity of linezolid, synercid and telithromcin against genetically defined high level fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus
    Bellido, JLM
    Zufiaurre, MNG
    Hernández, FJS
    Guirao, GY
    Hernández, MS
    García-Rodríguez, JA
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 20 (01) : 61 - 64
  • [37] Comparative in vitro activity of penicillin G, levofloxacin, moxifloxacin, telithromycin, pristinamycin, quinupristin-dalfopristin and linezolid against ofloxacin-intermediate and -resistant Streptococcus pneumoniae
    Frédénucci, I
    Chomarat, M
    Bercion, R
    Carricajo, A
    Celard, M
    Croizé, J
    Delubac, F
    Fèvre, D
    Fuhrmann, C
    Helfre, M
    Letouzey, MN
    Lelièvre, H
    Mandjee, A
    Marthelet, P
    Meley, R
    Perrier-Gros-Claude, JD
    Ros, A
    Roure, C
    Smati, S
    Thierry, J
    Tous, J
    CLINICAL MICROBIOLOGY AND INFECTION, 2002, 8 (10) : 680 - 683
  • [38] Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococci
    Shortridge, VD
    Zhong, P
    Cao, ZS
    Beyer, JA
    Almer, LS
    Ramer, NC
    Doktor, SZ
    Flamm, RK
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (03) : 783 - 786
  • [39] Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniae
    Jorgensen, JH
    Crawford, SA
    McElmeel, ML
    Whitney, CG
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (02) : 605 - 607
  • [40] Effect of low-level resistance on subsequent enrichment of fluoroquinolone-resistant Streptococcus pneumoniae in rabbits
    Etienne, M
    Croisier, D
    Charles, PE
    Lequeu, C
    Piroth, L
    Portier, H
    Drlica, K
    Chavanet, P
    JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (08): : 1472 - 1475
12345